|
|
Article: More OGD funding to benefit US consumers.(Office of Generic Drugs)
- Article from:
- Pharma Marketletter
- Article date:
- February 27, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The USA's Generic Pharmaceutical Association (GPhA), at its Annual Meeting, said providing a minimal amount of additional funding for the Office of Generic Drugs will produce a tremendous return on investment, resulting in long-lasting dividends to all health care purchasers and health care programs.
"A modest investment in [the] OGD - such as $15.0 million - would help to make more affordable medicines available to consumers and public and private health care purchasers, who would save billions of dollars," said GPhA president Kathleen Jaeger, adding: "those savings also would enable the administration to reach more Americans through its priority healthcare ...